Fearon ER - Search Results

1

CDX2 polymorphisms, RNA expression, and risk of colorectal cancer.

Rozek LS, Lipkin SM, Fearon ER, Hanash S, Giordano TJ, Greenson JK, Kuick R, Misek DE, Taylor JM, Douglas JA, Rennert G, Gruber SB. Rozek LS, et al. Among authors: fearon er. Cancer Res. 2005 Jul 1;65(13):5488-92. doi: 10.1158/0008-5472.CAN-04-3645. Cancer Res. 2005. PMID: 15994917

2

Transcriptional defects underlie loss of E-cadherin expression in breast cancer.

Ji X, Woodard AS, Rimm DL, Fearon ER. Ji X, et al. Among authors: fearon er. Cell Growth Differ. 1997 Jul;8(7):773-8. Cell Growth Differ. 1997. PMID: 9218871

3

Netrin-1: interaction with deleted in colorectal cancer (DCC) and alterations in brain tumors and neuroblastomas.

Meyerhardt JA, Caca K, Eckstrand BC, Hu G, Lengauer C, Banavali S, Look AT, Fearon ER. Meyerhardt JA, et al. Among authors: fearon er. Cell Growth Differ. 1999 Jan;10(1):35-42. Cell Growth Differ. 1999. PMID: 9950216

4

Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.

Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER. Caca K, et al. Among authors: fearon er. Cell Growth Differ. 1999 Jun;10(6):369-76. Cell Growth Differ. 1999. PMID: 10392898

5

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles.

Giordano TJ, Shedden KA, Schwartz DR, Kuick R, Taylor JM, Lee N, Misek DE, Greenson JK, Kardia SL, Beer DG, Rennert G, Cho KR, Gruber SB, Fearon ER, Hanash S. Giordano TJ, et al. Among authors: fearon er. Am J Pathol. 2001 Oct;159(4):1231-8. doi: 10.1016/S0002-9440(10)62509-6. Am J Pathol. 2001. PMID: 11583950 Free PMC article.

6

Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.

Wu R, Zhai Y, Fearon ER, Cho KR. Wu R, et al. Among authors: fearon er. Cancer Res. 2001 Nov 15;61(22):8247-55. Cancer Res. 2001. PMID: 11719457

7

Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon.

Hinoi T, Tani M, Lucas PC, Caca K, Dunn RL, Macri E, Loda M, Appelman HD, Cho KR, Fearon ER. Hinoi T, et al. Among authors: fearon er. Am J Pathol. 2001 Dec;159(6):2239-48. doi: 10.1016/S0002-9440(10)63074-X. Am J Pathol. 2001. PMID: 11733373 Free PMC article.

8

The SLUG zinc-finger protein represses E-cadherin in breast cancer.

Hajra KM, Chen DY, Fearon ER. Hajra KM, et al. Among authors: fearon er. Cancer Res. 2002 Mar 15;62(6):1613-8. Cancer Res. 2002. PMID: 11912130

9

Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.

Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR, Fearon ER. Leung JY, et al. Among authors: fearon er. J Biol Chem. 2002 Jun 14;277(24):21657-65. doi: 10.1074/jbc.M200139200. Epub 2002 Apr 8. J Biol Chem. 2002. PMID: 11940574 Free article.

10

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM, Cho KR. Schwartz DR, et al. Among authors: fearon er. Cancer Res. 2002 Aug 15;62(16):4722-9. Cancer Res. 2002. PMID: 12183431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters